Astrana Health Quarterly Cash Flow Statement
NASDAQ: ASTHConsumer DiscretionaryProfessional ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Astrana Health free cash flow
In the quarter ended Jun 30, 2026, Astrana Health generated $32.7 million of operating cash flow and spent $3.9 million on capital expenditures. That left free cash flow of $28.9 million, a free-cash-flow margin of 3.0% of revenue. Free cash flow was down 67.7% from the prior year's $89.5 million.
Astrana Health returned $95,000 to shareholders through dividends, equal to 0% of free cash flow. Free cash flow covered dividend payments 303.9 times.
Summary generated from market data by MetaCap's automated system. Methodology
Astrana Health cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20252026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 18.45M | 13.13M | 6.56M | 1.08M | 10.22M | 6.22M | -7.78M | 18.98M | 21.87M | 16.86M | -94.00K | 27.97M |
| Net Income growth (YoY) | +80.62% | +111.08% | — | -94.33% | -53.28% | -63.11% | — | -32.15% | +25.08% | +35.03% | — | +17.06% |
| Depreciation & Amortization | 15.55M | 15.48M | 16.40M | 15.60M | 6.90M | 6.85M | 8.13M | 7.26M | 7.44M | 5.10M | 4.90M | 4.30M |
| Stock-Based Compensation | 11.79M | 9.89M | 11.38M | 7.70M | 11.71M | 7.81M | 15.23M | 6.16M | 7.39M | 5.75M | 8.68M | 5.71M |
| Change in Working Capital | — | — | — | — | — | -10.67M | -60.50M | -1.45M | 11.53M | -25.13M | 29.69M | -27.38M |
| Operating Cash Flow | 32.75M | 68.06M | -2.89M | 9.96M | 90.90M | 16.63M | -10.95M | 33.98M | 23.19M | 5.98M | 19.30M | 15.40M |
| Capital Expenditures | -3.88M | -4.00M | -3.06M | -2.55M | -1.42M | -3.07M | -2.53M | -2.29M | -2.84M | -369.00K | -7.06M | -4.11M |
| Investing Cash Flow | -6.23M | -2.84M | -1.06M | -534.47M | -1.08M | -2.39M | -33.32M | -8.11M | -79.92M | -71.04M | -11.43M | -34.88M |
| Dividends Paid | -95.00K | -104.00K | -1.56M | -96.00K | -778.00K | -5.46M | -1.92M | -218.00K | -1.80M | -95.00K | -59.81M | -1.42M |
| Share Repurchases | 0 | -2.80M | -15.00M | 0 | 0 | -10.60M | -900.00K | 0 | — | — | -503.00K | -150.00K |
| Debt Issued | 0 | 0 | — | — | 0 | 412.00M | — | — | — | — | — | — |
| Debt Repaid | -91.97M | -11.97M | — | — | -3.13M | -428.23M | — | — | — | — | — | -149.00K |
| Financing Cash Flow | -104.07M | -15.96M | -26.34M | 648.49M | -8.64M | -44.17M | -15.27M | -3.19M | 47.25M | 106.35M | 11.99M | -510.00K |
| Net Change in Cash | -77.55M | 49.25M | -30.28M | 123.97M | 81.19M | -29.94M | -59.54M | 22.68M | -9.48M | 41.29M | 19.87M | -19.98M |
| Free Cash Flow | 28.87M | 64.06M | -5.95M | 7.40M | 89.48M | 13.56M | -13.48M | 31.69M | 20.35M | 5.61M | 12.24M | 11.30M |
This table shows 12 quarterly periods of Astrana Health's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ASTH's reporting calendar. What is a cash flow statement?